Home » Topics » Conferences

Conferences
RSS

Clinical safety and pharmacology of Vasoflux

Nov. 14, 1997

MMP inhibitors in cardiovascular medicine

Nov. 14, 1997

New formulation of amiodarone shows favorable hemodynamic effects

Nov. 13, 1997

Preclinical antiinflammatory effects demonstrated for CT-3

Nov. 13, 1997

Minocycline associated with marked long-term efficacy in early RA

Nov. 13, 1997

Alendronate and etidronate prevent steroid-induced osteoporosis

Nov. 13, 1997

Pharmacokinetics, peripheral antihistaminic and central effects of rupatadine in humans

Nov. 13, 1997

TNFR:Fc evaluated in patients with heart failure

Nov. 13, 1997

Lerisetron: a potent, selective, long-acting and orally effective 5-HT3 antagonist

Nov. 12, 1997

PDE IV inhibitor from Almirall does not stimulate gastric acid secretion in rats

Nov. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...